U.S. Senator Ted Budd (R-N.C.) introduced legislation today to expand and modernize eligibility requirements for the U.S. Department of Housing and Urban Development’s (HUD) Home Investment Partnerships (HOME) Program.

Washington, D.C. — U.S. Senator Ted Budd (R-N.C.) and U.S. Representative Mary Miller (R-Ill.-15) led several of their Republican colleagues in introducing the bicameral Stop Illegal Alien Cops Act today. The legislation is aimed at prohibiting illegal aliens who work as armed law enforcement officers from possessing firearms or ammunition provided to them by a government entity, such as a police department. This bill aligns with existing federal law that already prohibits illegal aliens from possessing firearms or ammunition in the United States. 

 U.S. Senators Ted Budd (R-N.C.) and John Fetterman (D-Pa.), members of the Senate Commerce, Science, and Transportation Committee, released the following statements after their National Programmable Cloud Lab Network (NPCLN) Act received overwhelming bipartisan support and passed out of committee yesterday.

 Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Kirsten Gillibrand (D-N.Y.) introduced the bipartisan, bicameral United States-Israel Framework for Upgraded Technologies, Unified Research, and Enhanced Security (FUTURES) Act today, which would strengthen cooperation on bilateral defense programs between the United States and Israel. This bill aims to expand and accelerate defense technology research, development, testing, evaluation, and industrial cooperation between both countries. 

Washington, D.C. — U.S. Senators Ted Budd (R-N.C.), Bill Cassidy (R-La.), Pete Ricketts (R-Neb.) and Thom Tillis (R-N.C.) introduced the Workforce Development Modernization Act today, which would amend the Workforce and Innovation Opportunity Act (WIOA) to give local Workforce Development Boards the option to create virtual One-Stop Centers, share resources with other workforce development regions and One-Stop Centers, or co-locate at community colleges.

Washington, D.C. — U.S. Senator Ted Budd (R-N.C.), member of the Senate Armed Services Committee, released the following statement after Congress passed the Fiscal Year (FY) 2026 Defense Appropriations Act. 

Washington, D.C. — U.S. Senator Ted Budd (R-N.C.) issued the following statement after casting his vote to pass the five-bill appropriations minibus and a two-week continuing resolution for the Department of Homeland Security (DHS). 

Washington, D.C. — This week, U.S. Senator Ted Budd (R-N.C.) introduced the Banning Perpetrators of Religious Persecution Act to amend the Immigration and Nationality Act (INA) by restricting the issuance of visas to individuals who have directed, authorized, significantly supported, participated in, or carried out violations of religious freedom. The bill would additionally amend the INA to expand visa ineligibility to terrorist or non-state actors responsible for violations of religious freedom, in addition to foreign government officials responsible for the persecution of religious groups.

Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Thom Tillis (R-N.C.) today announced their support for the nomination of Dan Bishop, former U.S. Congressman and Deputy Director of the Office of Management and Budget, to become the Senate-confirmed U.S. Attorney for the Middle District of North Carolina. 

 Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Jeanne Shaheen (D-N.H.), members of the Senate Armed Services Committee, introduced the bipartisan, bicameral Special Operator Protection Act today, to protect the identity of Special Operations Forces (SOF), federal law enforcement officers attached to SOF, and other Department of Defense (DOD) personnel who conduct highly sensitive DOD missions, by creating a criminal penalty for doxing their personally identifiable information. U.S. Representatives Richard Hudson (R-N.C.-09) and Pat Harrigan (R-N.C.-10) introduced the companion legislation in the House of Representatives.

Washington, D.C. — U.S. Senator Ted Budd (R-N.C.) released the following statement after the Department of Homeland Security (DHS) Secretary Kristi Noem today announced more than $72 million in Public Assistance (PA) grant program reimbursements and $44.6 million in Hazard Mitigation Grant Program (HMGP) funds for Hurricane Helene recovery projects across Western North Carolina. These HMGP funds are critical for protecting Western North Carolina from potential flooding and storm damage in the future. 

Earlier this month, U.S. Senator Ted Budd (R-N.C.) joined members of the North Carolina congressional delegation in sending a bipartisan, bicameral letter to the Administrator for the Centers for Medicare and Medicaid Services (CMS), Dr. Mehmet Oz, expressing strong support for the North Carolina Department of Health and Human Service’s (DHHS) Rural Health Transformation Program (RHTP) application.

Washington, D.C. — Senator Ted Budd (R-N.C.) released the following statement after President Trump signed an executive order that would reschedule marijuana from a Schedule I drug to a lower classification, easing federal restrictions on the substance: 

Washington, D.C. — Senator Ted Budd (R-N.C.), a member of the Senate Armed Services Committee (SASC), voted in favor of passage of the Fiscal Year (FY) 2026 National Defense Authorization Act (NDAA) today. The bill includes numerous provisions to improve readiness and quality of life for our troops, increase funding for North Carolina military installations, deter China, and strengthen alliances abroad. The defense package is now headed to the President’s desk to be signed into law. 

U.S. Senator Ted Budd (R-N.C.) issued the following statement after the U.S. Senate passed legislation that puts the Lumbee Tribe of North Carolina on the path to receive the full federal benefits they have long been unfairly denied.

Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Maggie Hassan (D-N.H.) introduced the bipartisan Biosimilar Inspection Modernization Act, legislation that would make prescription drugs more accessible and affordable by updating and improving the Food and Drug Administration’s (FDA) inspection processes for facilities manufacturing biosimilar medicines